Master Twist
An obscure indica-leaning hybrid marketed as a Master Kush cross, with more folklore than verified data behind it.
Master Twist is a minor-market strain with almost no independent verification behind its claims. Retailers list it as a Master Kush descendant with heavy relaxing effects, but there are no peer-reviewed studies on this cultivar, no verified breeder documentation we could locate, and no chemotype data from certified labs published in the scientific literature. Treat everything you read about it — including this article — as provisional. If you buy it, trust the COA in your hand over any online description, including ours.
Overview
Master Twist is a cannabis strain that circulates on seedbank and dispensary menus as an indica-dominant hybrid, usually described as a Master Kush derivative Weak / limited. It has no significant presence in peer-reviewed literature, cannabis competition records we could verify, or documented breeder catalogs from major seed houses. Most descriptions online trace back to a small number of retailer or aggregator pages that repeat similar language without citing a chemotype certificate of analysis (COA) or a breeder of record.
Because of this thin evidence base, this article focuses as much on what isn't known about Master Twist as on what is claimed. The general cannabis science we cite (on cannabinoids, terpenes, and indica/sativa labeling) is well supported [1][2][3]; the specific claims about this strain are not.
Chemistry: cannabinoids and terpenes
No published chemotype data specific to Master Twist appears in the scientific literature or in publicly available regulator datasets we could locate. Retailer listings commonly cite THC in the high teens to low 20s percent by dry weight and negligible CBD, which is unremarkable and typical for modern THC-dominant hybrids Weak / limited.
Terpene profile claims for Master Twist are inconsistent across sources — some list myrcene as dominant, others caryophyllene or limonene No data. There is no single verified profile. Independent chemotype work on commercial cannabis shows that strain name is a poor predictor of chemistry: samples sold under the same name from different producers routinely differ substantially in cannabinoid and terpene content [1][2] Strong evidence.
Practical implication: if you care about the actual chemistry of a jar labeled Master Twist, read the COA. Don't rely on the name.
Reported effects
Users and retailers describe Master Twist as producing body-heavy relaxation, mild euphoria, and sleepiness at higher doses Anecdote. These are the same descriptors applied to essentially every strain marketed as an indica or Kush descendant, and they should be read as genre conventions more than measured outcomes.
There are no clinical trials of Master Twist. There are no clinical trials of any named recreational cannabis cultivar in the sense consumers usually imagine — controlled studies use standardized preparations, not commercial strain names [3] Strong evidence. Individual response to cannabis is driven by dose, route (smoked, vaped, edible), tolerance, set and setting, and cannabinoid/terpene content — not by the strain name on the label [1][4] Strong evidence.
If someone tells you Master Twist specifically treats a condition, ask them what evidence they're basing that on. The honest answer is: none that meets a clinical standard.
Lineage (disputed)
Master Twist is most often described as a Master Kush cross, sometimes with a second parent listed vaguely as an unknown or 'proprietary' hybrid Disputed. We could not locate a breeder statement, pedigree registration, or genetic assay linking Master Twist to specific parents.
This is common in the cannabis market. Independent genotyping studies have repeatedly found that strain names do not map cleanly to genetic lineage: cultivars sold under the same name can be genetically distinct, and cultivars with different names can be nearly identical [5] Strong evidence. Without a chain of custody from a named breeder plus a genetic test, any lineage claim for Master Twist should be treated as marketing, not fact.
Cultivation basics
There is no authoritative grow guide for Master Twist from a verified breeder that we could locate. Retailer descriptions suggest an 8–9 week flowering window, moderate stretch, and Kush-typical dense flower structure Weak / limited. If the Master Kush lineage claim is accurate, growers can reasonably expect behavior similar to other Hindu Kush–descended indicas: compact plants, tolerance to indoor training, and susceptibility to bud rot in dense colas under humid conditions Weak / limited.
General cannabis cultivation guidance applies: control vapor pressure deficit in flower, keep late-flower relative humidity below roughly 55% to reduce Botrytis risk, and cure slowly for terpene retention [6] Strong evidence. None of this is specific to Master Twist.
Marketing vs. reality
The marketing story around Master Twist leans on three familiar tropes worth separating from evidence:
- 'Indica means couch-lock.' The indica/sativa binary does not reliably predict effects. Genetic and chemical analyses show the labels correlate poorly with either ancestry or chemotype [5][2] Strong evidence. A strain being called an indica tells you almost nothing useful about how it will feel.
- 'Master Kush lineage guarantees a specific high.' Even genuine Master Kush descendants vary widely in cannabinoid and terpene content between producers [1][2] Strong evidence. Lineage is not chemotype.
- 'Dominant terpene X causes effect Y.' Popular claims like 'myrcene above 0.5% causes sedation' are folklore — that specific threshold has no basis in published human research No data. Terpenes likely do modulate cannabis effects to some degree, but the size and direction of that effect in whole-flower use are still being studied [4] Weak / limited.
Bottom line: Master Twist is a name on a jar. Judge what's in the jar by the COA and by how it actually affects you at a controlled dose.
Sources
- Peer-reviewed Jikomes, N., & Zoorob, M. (2018). The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports, 8, 4519.
- Peer-reviewed Smith, C. J., et al. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Government National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
- Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1, 3.
- Peer-reviewed Punja, Z. K., et al. (2019). Pathogens and molds affecting production and quality of Cannabis sativa L. Frontiers in Plant Science, 10, 1120.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...